Salicylic acid is a classic non-steroidal anti-inflammatory drug. Although salicylic acid also induces mitochondrial injury, the mechanism of its anti-mitochondrial activity is not well understood. In this study, by using a one-step affinity purification scheme with salicylic acid-immobilized beads, ferrochelatase (FECH), a homodimeric enzyme involved in heme biosynthesis in mitochondria, was identified as a new molecular target of salicylic acid. Moreover, co-crystal structure of the FECH•salicylic acid complex was determined. Structural and biochemical studies showed that salicylic acid binds to the dimer interface of FECH in two possible orientations and inhibits its enzymatic activity. Mutational analysis confirmed that Trp301 and Leu311, hydrophobic amino acid residues located at the dimer interface, are directly involved in salicylic acid binding. On a gel filtration column, salicylic acid caused a shift in the elution profile of FECH, indicating that its conformational change is induced by salicylic acid binding. In cultured human cells, salicylic acid treatment or FECH knockdown inhibited heme synthesis, whereas salicylic acid did not exert its inhibitory effect in FECH knockdown cells. Concordantly, salicylic acid treatment or FECH knockdown inhibited heme synthesis in zebrafish embryos. Strikingly, the salicylic acid-induced effect in zebrafish was partially rescued by FECH overexpression.
Introduction
The therapeutic effect of willow bark, of which the active ingredient is now known to be salicylic acid, was first reported about 3500 years ago in Egyptian manuscripts (Nicolaou and Montagnon, 2008) . Originally recognized as an anti-pathogen plant hormone (Durner et al., 1997) , the drug was later chemically synthesized by Kolbe (Needs and Brooks, 1985) , leading to the development of the salicylic acid family of non-steroidal anti-inflammatory drugs. The most popular member of this family is aspirin or acetyl salicylic acid, which is rapidly hydrolyzed to salicylic acid by plasma esterase after administration (Grosser et al., 2009 ). In addition to analgesia, aspirin and salicylic acid can cause various adverse events, such as gastrointestinal toxicity, renal toxicity, hepatic injury, and neurological and respiratory imbalances (Grosser et al., 2009; Needs and Brooks, 1985) .
The anti-inflammatory effect of aspirin is generally thought to be caused by the inhibition of cyclooxygenase (COX) activity during prostaglandin biosynthesis (Vane, 1971; Vane and Botting, 2003) . Unlike aspirin, salicylic acid has almost no inhibitory activity against purified COX, but nevertheless inhibits prostaglandin synthesis in intact cells (Mitchell et al., 1993) . This suggests that other targets might account for the anti-inflammatory actions of salicylic acid. Indeed, IB kinase IKK-), a key enzyme in the nuclear factor (NF)-B pathway, is inhibited by aspirin and salicylic acid (Kopp and Ghosh, 1994; Yin et al., 1998) ; however, the actions of Figure 3C ). For cryoprotection, the crystals were soaked in a reservoir solution containing 25% ethylene glycol. X-ray diffraction data were collected at the SPring-8 beamline BL41XU facility (wavelength 1.0 Å, temperature 100 K, Japan Synchrotron Radiation Research Institute, Hyogo, Japan) and processed with HKL2000 software (Otwinowski and Minor, 1997) . Other crystallographic calculations were performed with the CCP4 package package (Collaborative Computational Project, 1994) . The structure of the FECH•SA complex was determined via the molecular replacement method, based on the structure of the apoenzyme (PDB code: 2HRC) (Medlock et al., 2007b ) as a search model with Molrep. Model building was accomplished with Coot (Emsley and Cowtan, 2004 ), and refinement was performed by using REFMAC5 (Steiner et al., 2003) and Phenix (Afonine et al., 2012) . Data collection and structure refinement statistics are summarized in Supplemental Gel filtration. Gel filtration was performed by using an AKTA explorer (GE Healthcare) equipped with a Superdex 200 10/300 column (GE Healthcare). For Figure 2F , FECH R115L (4 mg/ml) or FECH R115L/L311A (3 mg/ml) was first incubated with the indicated concentration of salicylic acid for 1 h at 4°C. Then, 100 µl of the sample was loaded onto the column using buffer IB-B (50 mM Tris-MOPS [pH 8.0], 100 mM KCl, 1.0% (w/v) sodium cholate, 250 mM imidazole) containing the same concentration of salicylic acid as column buffer. Eluate fractions (500 µl each)
were collected, and peak fractions were analyzed by SDS-PAGE and Coomassie Brilliant Blue staining. The column was calibrated with the protein markers (GE Healthcare) aldolase (158 kDa), ovalbumin (44 kDa), and ribonuclease-A (13.7 kDa).
Quantification of cellular heme content. Total heme was extracted and analyzed by ultra-high performance liquid chromatography (UPLC), essentially as described previously (Antonicka et al., 2003 0.2 ml/min by using a 30-50% acetonitrile gradient for the first minute, followed by a 50-95% acetonitrile gradient for the next 9 min. All column buffers contained 0.05% trifluoroacetic acid. The elution of heme was monitored by measuring the absorbance at 400 nm. The retention time of heme was confirmed by using commercially available hemin as the control (Frontier Scientific).
Quantification of NAD(P)H content. NAD(P)H content in cells was quantified by using the WST-8 assay (Nacalai Tesque). The assay is based on the extracellular reduction of WST-8 by NAD(P)H produced in the mitochondria (Berridge et al., 2005) .
K562 cells were seeded into 96-well plates at 5,000 cells/50 µl/well. Salicylic acid, m-HBA, or p-HBA (50 µl/well) was added to each well, and after 24 h of incubation at 37°C, WST-8 was added. The absorbance at 450 nm was determined by using a plate reader (Wallac 1420 ARVO SX). Data were reported as the percentage of the absorbance in untreated controls.
Mitochondrial membrane potential. Flow cytometry was used for the determination of mitochondrial membrane potential (MMP, ΔΨ). K562 cells were seeded into six-well dishes at 1 × 10 6 cells/ml/well. Salicylic acid, m-HBA, p-HBA (10 mM), or FCCP (10 µM; Sigma) was added (in 1 ml of the same medium) and incubated for 24 or 48 h. Cells were stained with 10 µM Rhodamine 123 (Sigma) for 15 min at 37°C, washed with PBS, and analyzed with a FACScalibur (Becton-Dickinson).
Zebrafish experiments. Zebrafish embryos (1 hpf); dechorionated by using 2 mg/ml protease type XIV (Sigma), were immersed in salicylic acid (0.5, 1, or 3 mM in E3 medium) for 47 h, as described previously (Ito et al., 2010) . Knockdown and rescue experiments were performed by microinjecting an antisense morpholino This article has not been copyedited and formatted. The final version may differ from this version.
oligonucleotide (1 to 2 ng) targeting zFECH (5'-CACGCGCCTCCTAAAACCGCCATTG-3'), with or without capped mRNA for zFECH (0.6 ng; Gene Tools, Philomath, OR, USA), as described previously (Ito et al., 2010) . Heme was visualized by o-dianisidine staining of 48 hpf embryos, as described previously (Ransom et al., 1996) . Accumulation of PpIX in living 48-hpf embryos was detected by fluorescence microscopy using its autofluorescence with illumination peak at 520-550 nm (Childs et al., 2000) .
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Results
Salicylic acid binds to FECH. To identify novel salicylic acid-binding proteins, FG beads were used (Sakamoto et al., 2009 ). An amino derivative of salicylic acid (Supplemental Figure 1A ) was conjugated to carboxylated FG beads (Supplemental Figure 1B) . K562 human erythroleukemia cell lysate was preincubated with different concentrations of free salicylic acid and then incubated with the salicylic acid-immobilized beads. After extensive washing, bound proteins were eluted by using sodium dodecyl sulfate (SDS)-containing sample buffer and then subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining. A polypeptide with an apparent molecular weight of ~40 kDa ( Figure 1A , top, arrow)
was associated with the salicylic acid-immobilized beads, and its binding was inhibited by increasing concentrations of free salicylic acid ( Figure 1A , top). Because none of the known targets of salicylic acid has a similar molecular weight, this protein was subjected to proteolytic digestion and tandem mass spectrometry. (Medlock et al., 2007b) .
However, the R115L mutant is considerably more stable in vitro (Burden et al., 1999; Wu et al., 2001) . We found that the binding efficiency of His-FECH R115L to salicylic acid beads was indistinguishable from that of wild-type FECH fused to glutathione-S-transferase (GST) (compare Figure 1B and Supplemental Figure 2C ).
Because FECH can employ Zn 2+ as a substrate (Li et al., 1987; Medlock et al., 2007b) , the formation of a Zn-PpIX complex from Zn
2+
and PpIX was examined in vitro by using purified recombinant FECH R115L. As expected, salicylic acid inhibited its enzymatic activity in a concentration-dependent manner ( Figure 1D ).
To gain insight into the functional importance of the above findings, we next performed structure-function analysis with free ortho-hydroxybenzoic acid (salicylic acid), meta-hydroxybenzoic acid (m-HBA), and para-hydroxybenzoic acid (p-HBA) (Supplemental Figure 1A ). To our knowledge, only a single study has compared the pharmacological actions of these three isomers (You, 1983) . This previous study showed that salicylic acid, but not its isomers, caused the swelling of rat liver mitochondria. Similarly, we found that free salicylic acid inhibited the association of FECH with salicylic acid-immobilized beads more efficiently than free m-HBA or free p-HBA ( Figure 1C ). Moreover, m-HBA and p-HBA had little effect on FECH activity in the same concentration range as salicylic acid ( Figure 1D ). These data indicate that salicylic acid specifically binds to FECH and inhibits its enzymatic activity.
In severe cases of rheumatic fever and rheumatoid arthritis, high doses of aspirin are administered, resulting in its metabolite, salicylic acid, increasing to concentrations of 1-3 mM in the plasma and above 4 mM in the tissue (Baggott et al., 1992) . To obtain quantitative data on the FECH-salicylic acid interaction, isothermal titration calorimetry was used. The dissociation constant of this interaction was in the This article has not been copyedited and formatted. The final version may differ from this version. Figures 2B and 2C ). The hydroxyl group of salicylic acid forms a hydrogen bond with the side chain of Ser281 at a distance of 2.7 or 2.8 Å (Figures 2B and 2C ). These residues form a dimer interface channel (Medlock et al., 2012) , and salicylic acid sits in the middle of the channel.
To test the validity of our structural data and to examine the amino acid residues of FECH important for its binding to salicylic acid, Val270, Ser281, Trp301, and Leu311 were mutated to alanine, and a binding assay was performed by using salicylic acid-immobilized beads and FECH R115L mutants. Figure 2D shows that the W301A (R115L/W301A) and L311A (R115L/L311A) point mutations, but not the S281A (R115L/S281A) point mutation, substantially reduced FECH binding to salicylic acid. The V270A (R115L/V270A) mutant bound to salicylic acid, albeit to a lesser extent than FECH R115L. These results suggest that the hydrogen bond between the hydroxyl group of salicylic acid and FECH Ser281 is dispensable and that the hydrophobic interactions of the benzene ring of salicylic acid with FECH Trp301 and Leu311 are critical to salicylic acid binding to the dimer interface.
Because the amino acid residues studied above are located at the dimer interface, it is possible that some of the point mutations inhibit salicylic acid binding indirectly by affecting the dimerization status of FECH. Gel filtration analysis was performed to test this hypothesis. While FECH R115L and R115L/S281A were eluted with an estimated molecular weight of ~90 kDa, R115L/V270A, R115L/W301A, and R115L/L311A were eluted with an estimated molecular weight of ~50 kDa (Supplemental Figure 3A) , suggesting that these mutants exist largely as monomers (summarized in Table 1 ). Because the monomeric mutant R115L/V270A retained significant salicylic acid-binding activity ( Figure 2D ), we concluded that the This article has not been copyedited and formatted. The final version may differ from this version. Trp301 and Leu311 are directly involved in salicylic acid binding, we analyzed these mutants in the monomeric background. As expected, an additional W301A or L311A mutation to R115L/V270A resulted in the loss of salicylic acid binding ( Figure 2D ).
These results are consistent with our structural data and together demonstrate that Trp301and Leu311 of FECH are directly involved in its binding to salicylic acid.
Monomeric bacterial FECH also binds to salicylic acid. FECH is widely conserved
across species, and bacterial homologs of FECH are known to function as monomers (Wu et al., 2001 ). This prompted us to investigate whether bacterial FECH also binds to salicylic acid. As a result, we found that recombinant FECH derived from
Escherichia coli bound to salicylic acid to the same extent as the human monomeric R115L/V270A FECH mutant ( Figure 2E ). Concordantly, amino acid residues critical for salicylic acid binding are conserved between mammalian and bacterial FECHs (Supplemental Figure 6) . The above finding strengthens our conclusion that the dimerization of FECH is not required for salicylic acid binding.
Salicylic acid induces conformational changes in FECH.
Since salicylic acid binds to the dimer interface of FECH, we next investigated the possibility that salicylic acid affects the dimerization status of FECH. For this purpose, gel filtration analysis was performed in the presence of different concentrations of salicylic acid. As shown in Figure 2F , the presence of salicylic acid clearly shifted the elution peak of FECH This article has not been copyedited and formatted. The final version may differ from this version. Figure 3B) , suggesting that the shift is specific and is mediated by salicylic acid binding to FECH. However, the shift was not as dramatic as that caused by the R115L/L311A mutation ( Figure 2F ), indicating that salicylic acid may cause a conformational change in the dimer rather than its complete dissociation. This finding apparently contradicts our structural data, which did not reveal any conformational change in FECH upon salicylic acid binding.
One explanation might be that the crystal structure we obtained only represents an initial binding state. Regardless, the salicylic acid-induced structural change, evidenced by gel filtration analysis, may be related to its inhibitory effect on FECH's enzymatic activity.
Salicylic acid inhibits heme synthesis and mitochondrial activity in K562 cells.
We next investigated the effect of salicylic acid on cellular heme biosynthesis by using UPLC. As shown in Figure 3A , salicylic acid treatment for 24 h resulted in a substantial reduction in the heme content of K562 cells, with a maximum decrease of 64±3% observed at 10 mM. The effects of m-HBA and p-HBA were comparatively weak, with maximum decreases of 16±2% and 15±4%, respectively, at 10 mM. Hence, salicylic acid, but not m-HBA and p-HBA, inhibits FECH activity both in cell-free assays and K562 cells. , 1999) , this is, to our knowledge, the first comparative study of salicylic acid and its isomers.
FECH is responsible for the inhibitory effect of salicylic acid on heme synthesis.
To investigate the functional link between FECH and salicylic acid more critically, we knocked down FECH in 293T cells by transducing lentiviral vectors expressing one of two shRNAs against FECH ( Figure 4A ). Then, the cellular levels of heme was measured with or without prior incubation with 1, 3 and 10 mM of salicylic acid. FECH knockdown alone resulted in a reduction of the cellular heme level (data not shown).
Moreover, FECH knockdown abolished salicylic acid-induced reduction of the heme level at all concentration of salicylic acid ( Figure 4B ), suggesting that FECH is responsible for the inhibitory effect of salicylic acid on heme synthesis, and mediating some of its pharmacological effects.
This article has not been copyedited and formatted. The final version may differ from this version. are 79% identical, and moreover, several amino acid residues important for salicylic acid binding are conserved between the species (Supplemental Figure 6 ). We first investigated whether zFECH binds to salicylic acid and found that zFECH binds to salicylic acid-immobilized beads as efficiently as human FECH (Supplemental Figure   2C ).
We next analyzed the effect of salicylic acid on heme synthesis during zebrafish development by o-dianisidine staining of heme. In control 48 h post-fertilization (hpf) embryos, hematocytes in the blood sinus covering the yolk were stained in a granular pattern ( Figure 5A ). A small embryo-to-embryo variation was observed in o-dianisidine staining, probably due to the different running patterns of the blood sinus. While zFECH-knockdown (zFECH antisense morpholino oligonucleotide) or salicylic acid-treated embryos showed no gross morphological abnormalities (Supplemental Figure 5) , o-dianisidine staining was generally decreased in these embryos ( Figure 5B ). The spectrum of embryonic phenotypes was divided into "strong," "intermediate", and "weak" categories, based on the staining intensity and the diagnostic criteria shown in Figure 5A . While almost all of the zFECH-knockdown embryos showed a reduction in heme biosynthesis, co-injection of zFECH mRNA partially restored production of heme ( Figure 5B ).
Similarly, salicylic acid (1 or 3 mM) strongly inhibited heme generation in a concentration-dependent manner ( Figure 5B ), in agreement with our findings in vitro and in cultured cells. Remarkably, overexpression of zFECH in salicylic acid-treated embryos partially restored heme production ( Figure 5C ). By contrast, m-HBA and p-HBA had no significant effect on heme production in zebrafish ( Figure 5D ).
This article has not been copyedited and formatted. The final version may differ from this version. substrate PpIX may be conversely accumulated in affected embryos. Hence, PpIX auto-fluorescence in zebrafish embryos was examined under a fluorescence microscope at an illumination peak of 520-550 nm. As expected, zFECH knockdown embryos showed a substantial accumulation of PpIX in the blood sinus covering the yolk, and this accumulation was reversed by simultaneous overexpression of zFECH ( Figure 5E ). Similarly, salicylic acid-treated embryos showed a substantial increase in the PpIX level. Thus, these results indicate that salicylic acid inhibits heme biosynthesis by inhibiting FECH activity during zebrafish development.
This article has not been copyedited and formatted. The final version may differ from this version. Figure 1A) ; (ii) salicylic acid inhibits the enzymatic activity of recombinant FECH in vitro ( Figure 1D ); (iii) salicylic acid binds to FECH at the dimer interface, which is thought to be critical for its activity ( How does FECH discriminate salicylic acid from its isomers? Salicylic acid is known to have higher lipid solubility than m-HBA and p-HBA (Kunze et al.,1972) . This occurs because the negative charge of the carboxylate of salicylic acid is delocalized through intramolecular hydrogen bonding between the carboxyl group and the hydroxyl group. Thus, salicylate may move into the hydrophobic dimer interface of FECH more easily than meta-or para-hydroxybenzoate. Another possibility may be that the hydrogen bond between the hydroxyl group of salicylic acid and FECH Ser281 contributes to isoform specificity. However, this idea is not consistent with our mutational analysis showing that the hydrogen bond is dispensable for their interaction ( Figure 2D ). Yet another possibility is that the hydroxyl group of m-HBA negative charge of salicylic acid may cause conformational changes in the FECH dimer interface and thereby inhibit its enzymatic activity.
Here we showed that salicylic acid affects heme content, NAD(P)H content, and mitochondrial membrane potential at millimolar concentrations in K562 cells.
Similarly, previous studies showed that salicylic acid inhibits oxidative phosphorylation and decreases the ATP:AMP ratio at similar concentrations (Cronstein et al., 1999) . These consequences can result from the inhibition of FECH because its inhibition should result in the loss of activity of heme proteins, such as cytochromes, that are essential for the generation of mitochondrial membrane potential and ATP synthesis, among others (Atamna et al., 2001; Atamna et al., 2002; Gatta et al., 2009; Möbius et al., 2010) . It is also possible that other known targets of salicylic acid (e.g., COX, AMPK, and IKK-) are involved in the mitochondrial dysfunction. In regard to COX, salicylic acid has little, if any, effect on the enzymatic activity of purified COX (Mitchell et al., 1993) . Thus, it seems unlikely that COX plays a role in the salicylic acid-induced mitochondrial dysfunction. In regard to AMPK, salicylic acid is known to activate the essential regulator of energy metabolism (Hawley et al., 2012) . This should result in an increase in ATP synthesis; in fact, however, salicylic acid inhibited mitochondrial ATP synthesis (Cronstein et al., 1999) .
Therefore, the AMPK pathway does not seem to be involved in the salicylic acid-induced mitochondrial injury. In regard to IKK-, salicylic acid inhibits its protein kinase activity and attenuates inflammatory and immune responses involving NF-B (Kopp and Ghosh, 1994; Yin et al., 1998) . Since NF-B is a crucial regulator of cellular energy metabolism (Mauro et al., 2011) , its inhibition by salicylic acid can affect mitochondrial energy metabolism. Hence, the mitochondrial dysfunction induced by salicylic acid may be due to a combination of inhibitory actions on FECH and the NF-B pathway.
This article has not been copyedited and formatted. The final version may differ from this version. Although highly speculative, the present findings may have relevance to the anti-inflammatory actions of salicylic acid. Aspirin (acetyl salicylic acid) inhibits COX by transferring its acetyl group to the active site of prostaglandin synthase (Loll et al., 1995) . Despite the absence of the acetyl group and no significant effect on purified COX, salicylic acid has similar anti-inflammatory effects in vivo and can inhibit COX activity in cell-based assays (Mitchell et al., 1993) . fluorescence microscopy using its autofluorescence with illumination peak at 520-550 nm. Scale bar, 150 µm. Statistical significance was determined by applying the chi-square contingency test. *p<0.05, ***p<0.0001.
